Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1984)
  2. Solid Tumor Oncology Division (1616)
  3. GSK Faculty (761)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (412)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2092)
  2. Meeting Abstract (2072)
  3. Book Section (187)
  4. Review (88)
  5. Editorial (80)
  6. Guidelines (36)
  7. Correspondence (24)
  8. Book Whole (17)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1984)
  2. Solid Tumor Oncology Division (1616)
  3. GSK Faculty (761)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (73)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1667)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (209)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: Extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
    Journal Article

    Tannir, N. M.; Albigès, L.; McDermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthélémy, P.; Plimack, E. R.; Porta, C.; George, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
    Journal Article

    Bercz, A.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Sarkar, R.; Yamner, M.; Omer, D.; Verheij, F. S.; Alvarez, J.; Atri, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • ESMO recommendations on clinical reporting of genomic test results for solid cancers
    Guidelines

    van de Haar, J.; Roepman, P.; Andre, F.; Balmaña, J.; Castro, E.; Chakravarty, D.; Curigliano, G.; Czarnecka, A. M.; Dienstmann, R.; Horak, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: Final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Journal Article

    Monk, B. J.; Barretina-Ginesta, M. P.; Pothuri, B.; Vergote, I.; Graybill, W.; Mirza, M. R.; McCormick, C. C.; Lorusso, D.; Moore, R. G.; Freyer, G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): A tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
    Journal Article

    Westphalen, C. B.; Martins-Branco, D.; Beal, J. R.; Cardone, C.; Coleman, N.; Schram, A. M.; Halabi, S.; Michiels, S.; Yap, C.; André, F.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions
    Review

    Wilcox, J. A.; Chukwueke, U. N.; Ahn, M. J.; Aizer, A. A.; Bale, T. A.; Brandsma, D.; Brastianos, P. K.; Chang, S.; Daras, M.; Forsyth, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Separation surgery for metastatic spine tumors: How less became more
    Review

    Zhang, X.; Larsen, A. G.; Kharas, N.; Bilsky, M. H.; Newman, W. C.
    Neuro-Oncology Advances (2024)

    Fulltext@MSK | Save
  • Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: A Children's Oncology Group report
    Journal Article

    Ilcisin, L.; Han, R.; Krailo, M.; Shulman, D. S.; Weil, B. R.; Weldon, C. B.; Umaretiya, P.; Aziz-Bose, R.; Greenzang, K. A.; Gorlick, R.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors
    Journal Article

    Dinh, P. C. Jr; Monahan, P. O.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Vaughn, D. J.; Hamilton, R. J.; Huddart, R.; Martin, N. E.; Kollmannsberger, C.; more...
    JNCI Cancer Spectrum (2024)

    Fulltext@MSK | Save
  • Report on Pediatric Brain Tumor Consortium (PBTC)-029b, a prospective phase 2 clinical trial of selumetinib in treating young patients with recurrent/progressive low-grade glioma: New results on strata 2, 5, and 6 with updated long-term survival outcomes on strata 1, 3, and 4
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Kilburn, L.; Lenzen, A.; Pillay-Smiley, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save